nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabumetone—rheumatoid arthritis—Gabapentin—epilepsy syndrome	0.428	1	CpDpCtD
Nabumetone—PTGS2—epilepsy syndrome	0.153	1	CbGaD
Nabumetone—PTGS1—Diazepam—epilepsy syndrome	0.0441	0.213	CbGbCtD
Nabumetone—PTGS1—Valproic Acid—epilepsy syndrome	0.0348	0.168	CbGbCtD
Nabumetone—CYP1A2—Carbamazepine—epilepsy syndrome	0.026	0.126	CbGbCtD
Nabumetone—CYP1A2—Primidone—epilepsy syndrome	0.0243	0.117	CbGbCtD
Nabumetone—CYP1A2—Propofol—epilepsy syndrome	0.0217	0.105	CbGbCtD
Nabumetone—CYP1A2—Phenobarbital—epilepsy syndrome	0.0208	0.1	CbGbCtD
Nabumetone—CYP1A2—Diazepam—epilepsy syndrome	0.0197	0.0952	CbGbCtD
Nabumetone—CYP1A2—Valproic Acid—epilepsy syndrome	0.0155	0.0751	CbGbCtD
Nabumetone—Naproxen—SLCO1A2—epilepsy syndrome	0.000842	0.596	CrCbGaD
Nabumetone—Melatonin—CYP2C19—epilepsy syndrome	0.000241	0.171	CrCbGaD
Nabumetone—Naproxen—PTGS2—epilepsy syndrome	0.000174	0.123	CrCbGaD
Nabumetone—Naproxen—ALB—epilepsy syndrome	0.000155	0.11	CrCbGaD
Nabumetone—Malaise—Pregabalin—epilepsy syndrome	6.24e-05	0.000352	CcSEcCtD
Nabumetone—Nausea—Propofol—epilepsy syndrome	6.24e-05	0.000351	CcSEcCtD
Nabumetone—Tension—Gabapentin—epilepsy syndrome	6.23e-05	0.000351	CcSEcCtD
Nabumetone—Vomiting—Fosphenytoin—epilepsy syndrome	6.23e-05	0.000351	CcSEcCtD
Nabumetone—Diarrhoea—Felbamate—epilepsy syndrome	6.22e-05	0.000351	CcSEcCtD
Nabumetone—Vertigo—Pregabalin—epilepsy syndrome	6.22e-05	0.00035	CcSEcCtD
Nabumetone—Abdominal pain—Lamotrigine—epilepsy syndrome	6.22e-05	0.00035	CcSEcCtD
Nabumetone—Body temperature increased—Lamotrigine—epilepsy syndrome	6.22e-05	0.00035	CcSEcCtD
Nabumetone—Dizziness—Diazepam—epilepsy syndrome	6.21e-05	0.00035	CcSEcCtD
Nabumetone—Syncope—Pregabalin—epilepsy syndrome	6.21e-05	0.00035	CcSEcCtD
Nabumetone—Leukopenia—Pregabalin—epilepsy syndrome	6.2e-05	0.000349	CcSEcCtD
Nabumetone—Rash—Fosphenytoin—epilepsy syndrome	6.17e-05	0.000348	CcSEcCtD
Nabumetone—Dermatitis—Fosphenytoin—epilepsy syndrome	6.17e-05	0.000347	CcSEcCtD
Nabumetone—Haemoglobin—Topiramate—epilepsy syndrome	6.16e-05	0.000347	CcSEcCtD
Nabumetone—Nervousness—Gabapentin—epilepsy syndrome	6.16e-05	0.000347	CcSEcCtD
Nabumetone—Asthenia—Clonazepam—epilepsy syndrome	6.16e-05	0.000347	CcSEcCtD
Nabumetone—Headache—Fosphenytoin—epilepsy syndrome	6.14e-05	0.000346	CcSEcCtD
Nabumetone—Haemorrhage—Topiramate—epilepsy syndrome	6.13e-05	0.000345	CcSEcCtD
Nabumetone—Thrombocytopenia—Valproic Acid—epilepsy syndrome	6.12e-05	0.000345	CcSEcCtD
Nabumetone—Palpitations—Pregabalin—epilepsy syndrome	6.12e-05	0.000344	CcSEcCtD
Nabumetone—Asthenia—Phenytoin—epilepsy syndrome	6.12e-05	0.000344	CcSEcCtD
Nabumetone—Nausea—Midazolam—epilepsy syndrome	6.1e-05	0.000344	CcSEcCtD
Nabumetone—Diarrhoea—Zonisamide—epilepsy syndrome	6.09e-05	0.000343	CcSEcCtD
Nabumetone—Loss of consciousness—Pregabalin—epilepsy syndrome	6.08e-05	0.000343	CcSEcCtD
Nabumetone—Asthenia—Oxcarbazepine—epilepsy syndrome	6.08e-05	0.000343	CcSEcCtD
Nabumetone—Pruritus—Clonazepam—epilepsy syndrome	6.07e-05	0.000342	CcSEcCtD
Nabumetone—Vomiting—Vigabatrin—epilepsy syndrome	6.07e-05	0.000342	CcSEcCtD
Nabumetone—Hyperhidrosis—Valproic Acid—epilepsy syndrome	6.04e-05	0.00034	CcSEcCtD
Nabumetone—Cough—Pregabalin—epilepsy syndrome	6.04e-05	0.00034	CcSEcCtD
Nabumetone—Pruritus—Phenytoin—epilepsy syndrome	6.03e-05	0.00034	CcSEcCtD
Nabumetone—Nausea—Levetiracetam—epilepsy syndrome	6.03e-05	0.000339	CcSEcCtD
Nabumetone—Rash—Vigabatrin—epilepsy syndrome	6.02e-05	0.000339	CcSEcCtD
Nabumetone—Dizziness—Felbamate—epilepsy syndrome	6.01e-05	0.000339	CcSEcCtD
Nabumetone—Dermatitis—Vigabatrin—epilepsy syndrome	6.01e-05	0.000339	CcSEcCtD
Nabumetone—Pruritus—Oxcarbazepine—epilepsy syndrome	6e-05	0.000338	CcSEcCtD
Nabumetone—Hypersensitivity—Carbamazepine—epilepsy syndrome	5.99e-05	0.000338	CcSEcCtD
Nabumetone—Headache—Vigabatrin—epilepsy syndrome	5.98e-05	0.000337	CcSEcCtD
Nabumetone—Hypertension—Pregabalin—epilepsy syndrome	5.98e-05	0.000337	CcSEcCtD
Nabumetone—Vomiting—Diazepam—epilepsy syndrome	5.98e-05	0.000337	CcSEcCtD
Nabumetone—Anorexia—Valproic Acid—epilepsy syndrome	5.96e-05	0.000335	CcSEcCtD
Nabumetone—Tremor—Gabapentin—epilepsy syndrome	5.95e-05	0.000335	CcSEcCtD
Nabumetone—Rash—Diazepam—epilepsy syndrome	5.93e-05	0.000334	CcSEcCtD
Nabumetone—Dermatitis—Diazepam—epilepsy syndrome	5.92e-05	0.000333	CcSEcCtD
Nabumetone—Visual impairment—Topiramate—epilepsy syndrome	5.91e-05	0.000333	CcSEcCtD
Nabumetone—Ill-defined disorder—Gabapentin—epilepsy syndrome	5.89e-05	0.000332	CcSEcCtD
Nabumetone—Dizziness—Zonisamide—epilepsy syndrome	5.89e-05	0.000332	CcSEcCtD
Nabumetone—Headache—Diazepam—epilepsy syndrome	5.89e-05	0.000332	CcSEcCtD
Nabumetone—Anxiety—Pregabalin—epilepsy syndrome	5.87e-05	0.000331	CcSEcCtD
Nabumetone—Diarrhoea—Clonazepam—epilepsy syndrome	5.87e-05	0.000331	CcSEcCtD
Nabumetone—Anaemia—Gabapentin—epilepsy syndrome	5.87e-05	0.00033	CcSEcCtD
Nabumetone—Asthenia—Carbamazepine—epilepsy syndrome	5.84e-05	0.000329	CcSEcCtD
Nabumetone—Agitation—Gabapentin—epilepsy syndrome	5.83e-05	0.000328	CcSEcCtD
Nabumetone—Diarrhoea—Phenytoin—epilepsy syndrome	5.83e-05	0.000328	CcSEcCtD
Nabumetone—Discomfort—Pregabalin—epilepsy syndrome	5.82e-05	0.000328	CcSEcCtD
Nabumetone—Nausea—Fosphenytoin—epilepsy syndrome	5.82e-05	0.000328	CcSEcCtD
Nabumetone—Diarrhoea—Oxcarbazepine—epilepsy syndrome	5.8e-05	0.000327	CcSEcCtD
Nabumetone—Erythema multiforme—Topiramate—epilepsy syndrome	5.8e-05	0.000327	CcSEcCtD
Nabumetone—Angioedema—Gabapentin—epilepsy syndrome	5.8e-05	0.000327	CcSEcCtD
Nabumetone—Hypersensitivity—Lamotrigine—epilepsy syndrome	5.79e-05	0.000326	CcSEcCtD
Nabumetone—Vomiting—Felbamate—epilepsy syndrome	5.78e-05	0.000326	CcSEcCtD
Nabumetone—Dry mouth—Pregabalin—epilepsy syndrome	5.76e-05	0.000325	CcSEcCtD
Nabumetone—Pruritus—Carbamazepine—epilepsy syndrome	5.76e-05	0.000324	CcSEcCtD
Nabumetone—Rash—Felbamate—epilepsy syndrome	5.74e-05	0.000323	CcSEcCtD
Nabumetone—Dermatitis—Felbamate—epilepsy syndrome	5.73e-05	0.000323	CcSEcCtD
Nabumetone—Malaise—Gabapentin—epilepsy syndrome	5.72e-05	0.000322	CcSEcCtD
Nabumetone—Tinnitus—Topiramate—epilepsy syndrome	5.72e-05	0.000322	CcSEcCtD
Nabumetone—Vertigo—Gabapentin—epilepsy syndrome	5.7e-05	0.000321	CcSEcCtD
Nabumetone—Headache—Felbamate—epilepsy syndrome	5.7e-05	0.000321	CcSEcCtD
Nabumetone—Confusional state—Pregabalin—epilepsy syndrome	5.7e-05	0.000321	CcSEcCtD
Nabumetone—Syncope—Gabapentin—epilepsy syndrome	5.69e-05	0.000321	CcSEcCtD
Nabumetone—Leukopenia—Gabapentin—epilepsy syndrome	5.68e-05	0.00032	CcSEcCtD
Nabumetone—Dizziness—Clonazepam—epilepsy syndrome	5.67e-05	0.00032	CcSEcCtD
Nabumetone—Nausea—Vigabatrin—epilepsy syndrome	5.67e-05	0.000319	CcSEcCtD
Nabumetone—Vomiting—Zonisamide—epilepsy syndrome	5.66e-05	0.000319	CcSEcCtD
Nabumetone—Insomnia—Valproic Acid—epilepsy syndrome	5.65e-05	0.000318	CcSEcCtD
Nabumetone—Anaphylactic shock—Pregabalin—epilepsy syndrome	5.65e-05	0.000318	CcSEcCtD
Nabumetone—Oedema—Pregabalin—epilepsy syndrome	5.65e-05	0.000318	CcSEcCtD
Nabumetone—Asthenia—Lamotrigine—epilepsy syndrome	5.64e-05	0.000318	CcSEcCtD
Nabumetone—Dizziness—Phenytoin—epilepsy syndrome	5.64e-05	0.000317	CcSEcCtD
Nabumetone—Rash—Zonisamide—epilepsy syndrome	5.61e-05	0.000316	CcSEcCtD
Nabumetone—Paraesthesia—Valproic Acid—epilepsy syndrome	5.61e-05	0.000316	CcSEcCtD
Nabumetone—Palpitations—Gabapentin—epilepsy syndrome	5.61e-05	0.000316	CcSEcCtD
Nabumetone—Dermatitis—Zonisamide—epilepsy syndrome	5.61e-05	0.000316	CcSEcCtD
Nabumetone—Dizziness—Oxcarbazepine—epilepsy syndrome	5.61e-05	0.000316	CcSEcCtD
Nabumetone—Nausea—Diazepam—epilepsy syndrome	5.58e-05	0.000314	CcSEcCtD
Nabumetone—Loss of consciousness—Gabapentin—epilepsy syndrome	5.58e-05	0.000314	CcSEcCtD
Nabumetone—Headache—Zonisamide—epilepsy syndrome	5.58e-05	0.000314	CcSEcCtD
Nabumetone—Dyspnoea—Valproic Acid—epilepsy syndrome	5.57e-05	0.000314	CcSEcCtD
Nabumetone—Diarrhoea—Carbamazepine—epilepsy syndrome	5.57e-05	0.000314	CcSEcCtD
Nabumetone—Pruritus—Lamotrigine—epilepsy syndrome	5.56e-05	0.000313	CcSEcCtD
Nabumetone—Shock—Pregabalin—epilepsy syndrome	5.56e-05	0.000313	CcSEcCtD
Nabumetone—Somnolence—Valproic Acid—epilepsy syndrome	5.55e-05	0.000313	CcSEcCtD
Nabumetone—Cough—Gabapentin—epilepsy syndrome	5.54e-05	0.000312	CcSEcCtD
Nabumetone—Thrombocytopenia—Pregabalin—epilepsy syndrome	5.53e-05	0.000311	CcSEcCtD
Nabumetone—Chills—Topiramate—epilepsy syndrome	5.5e-05	0.00031	CcSEcCtD
Nabumetone—Dyspepsia—Valproic Acid—epilepsy syndrome	5.5e-05	0.00031	CcSEcCtD
Nabumetone—Hypertension—Gabapentin—epilepsy syndrome	5.48e-05	0.000309	CcSEcCtD
Nabumetone—Hyperhidrosis—Pregabalin—epilepsy syndrome	5.46e-05	0.000308	CcSEcCtD
Nabumetone—Vomiting—Clonazepam—epilepsy syndrome	5.46e-05	0.000307	CcSEcCtD
Nabumetone—Decreased appetite—Valproic Acid—epilepsy syndrome	5.43e-05	0.000306	CcSEcCtD
Nabumetone—Alopecia—Topiramate—epilepsy syndrome	5.42e-05	0.000305	CcSEcCtD
Nabumetone—Vomiting—Phenytoin—epilepsy syndrome	5.42e-05	0.000305	CcSEcCtD
Nabumetone—Rash—Clonazepam—epilepsy syndrome	5.41e-05	0.000305	CcSEcCtD
Nabumetone—Dermatitis—Clonazepam—epilepsy syndrome	5.41e-05	0.000304	CcSEcCtD
Nabumetone—Nausea—Felbamate—epilepsy syndrome	5.4e-05	0.000304	CcSEcCtD
Nabumetone—Vomiting—Oxcarbazepine—epilepsy syndrome	5.39e-05	0.000304	CcSEcCtD
Nabumetone—Fatigue—Valproic Acid—epilepsy syndrome	5.39e-05	0.000303	CcSEcCtD
Nabumetone—Anxiety—Gabapentin—epilepsy syndrome	5.38e-05	0.000303	CcSEcCtD
Nabumetone—Anorexia—Pregabalin—epilepsy syndrome	5.38e-05	0.000303	CcSEcCtD
Nabumetone—Dizziness—Carbamazepine—epilepsy syndrome	5.38e-05	0.000303	CcSEcCtD
Nabumetone—Diarrhoea—Lamotrigine—epilepsy syndrome	5.38e-05	0.000303	CcSEcCtD
Nabumetone—Headache—Clonazepam—epilepsy syndrome	5.38e-05	0.000303	CcSEcCtD
Nabumetone—Rash—Phenytoin—epilepsy syndrome	5.37e-05	0.000303	CcSEcCtD
Nabumetone—Dermatitis—Phenytoin—epilepsy syndrome	5.37e-05	0.000302	CcSEcCtD
Nabumetone—Rash—Oxcarbazepine—epilepsy syndrome	5.35e-05	0.000301	CcSEcCtD
Nabumetone—Constipation—Valproic Acid—epilepsy syndrome	5.34e-05	0.000301	CcSEcCtD
Nabumetone—Dermatitis—Oxcarbazepine—epilepsy syndrome	5.34e-05	0.000301	CcSEcCtD
Nabumetone—Headache—Phenytoin—epilepsy syndrome	5.34e-05	0.000301	CcSEcCtD
Nabumetone—Discomfort—Gabapentin—epilepsy syndrome	5.34e-05	0.000301	CcSEcCtD
Nabumetone—Headache—Oxcarbazepine—epilepsy syndrome	5.31e-05	0.000299	CcSEcCtD
Nabumetone—Nausea—Zonisamide—epilepsy syndrome	5.29e-05	0.000298	CcSEcCtD
Nabumetone—Dry mouth—Gabapentin—epilepsy syndrome	5.28e-05	0.000298	CcSEcCtD
Nabumetone—Flatulence—Topiramate—epilepsy syndrome	5.26e-05	0.000296	CcSEcCtD
Nabumetone—Tension—Topiramate—epilepsy syndrome	5.24e-05	0.000295	CcSEcCtD
Nabumetone—Confusional state—Gabapentin—epilepsy syndrome	5.22e-05	0.000294	CcSEcCtD
Nabumetone—Dizziness—Lamotrigine—epilepsy syndrome	5.2e-05	0.000293	CcSEcCtD
Nabumetone—Nervousness—Topiramate—epilepsy syndrome	5.19e-05	0.000292	CcSEcCtD
Nabumetone—Oedema—Gabapentin—epilepsy syndrome	5.18e-05	0.000292	CcSEcCtD
Nabumetone—Anaphylactic shock—Gabapentin—epilepsy syndrome	5.18e-05	0.000292	CcSEcCtD
Nabumetone—Vomiting—Carbamazepine—epilepsy syndrome	5.17e-05	0.000291	CcSEcCtD
Nabumetone—Feeling abnormal—Valproic Acid—epilepsy syndrome	5.15e-05	0.00029	CcSEcCtD
Nabumetone—Rash—Carbamazepine—epilepsy syndrome	5.13e-05	0.000289	CcSEcCtD
Nabumetone—Dermatitis—Carbamazepine—epilepsy syndrome	5.13e-05	0.000289	CcSEcCtD
Nabumetone—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	5.11e-05	0.000288	CcSEcCtD
Nabumetone—Insomnia—Pregabalin—epilepsy syndrome	5.11e-05	0.000288	CcSEcCtD
Nabumetone—Nausea—Clonazepam—epilepsy syndrome	5.1e-05	0.000287	CcSEcCtD
Nabumetone—Headache—Carbamazepine—epilepsy syndrome	5.1e-05	0.000287	CcSEcCtD
Nabumetone—Shock—Gabapentin—epilepsy syndrome	5.1e-05	0.000287	CcSEcCtD
Nabumetone—Paraesthesia—Pregabalin—epilepsy syndrome	5.07e-05	0.000286	CcSEcCtD
Nabumetone—Thrombocytopenia—Gabapentin—epilepsy syndrome	5.07e-05	0.000286	CcSEcCtD
Nabumetone—Nausea—Phenytoin—epilepsy syndrome	5.06e-05	0.000285	CcSEcCtD
Nabumetone—Dyspnoea—Pregabalin—epilepsy syndrome	5.04e-05	0.000284	CcSEcCtD
Nabumetone—Nausea—Oxcarbazepine—epilepsy syndrome	5.04e-05	0.000284	CcSEcCtD
Nabumetone—Somnolence—Pregabalin—epilepsy syndrome	5.02e-05	0.000283	CcSEcCtD
Nabumetone—Hyperhidrosis—Gabapentin—epilepsy syndrome	5.01e-05	0.000282	CcSEcCtD
Nabumetone—Tremor—Topiramate—epilepsy syndrome	5e-05	0.000282	CcSEcCtD
Nabumetone—Vomiting—Lamotrigine—epilepsy syndrome	5e-05	0.000282	CcSEcCtD
Nabumetone—Urticaria—Valproic Acid—epilepsy syndrome	4.96e-05	0.00028	CcSEcCtD
Nabumetone—Rash—Lamotrigine—epilepsy syndrome	4.96e-05	0.000279	CcSEcCtD
Nabumetone—Ill-defined disorder—Topiramate—epilepsy syndrome	4.95e-05	0.000279	CcSEcCtD
Nabumetone—Dermatitis—Lamotrigine—epilepsy syndrome	4.95e-05	0.000279	CcSEcCtD
Nabumetone—Body temperature increased—Valproic Acid—epilepsy syndrome	4.94e-05	0.000278	CcSEcCtD
Nabumetone—Abdominal pain—Valproic Acid—epilepsy syndrome	4.94e-05	0.000278	CcSEcCtD
Nabumetone—Anorexia—Gabapentin—epilepsy syndrome	4.94e-05	0.000278	CcSEcCtD
Nabumetone—Anaemia—Topiramate—epilepsy syndrome	4.94e-05	0.000278	CcSEcCtD
Nabumetone—Headache—Lamotrigine—epilepsy syndrome	4.93e-05	0.000277	CcSEcCtD
Nabumetone—Decreased appetite—Pregabalin—epilepsy syndrome	4.91e-05	0.000277	CcSEcCtD
Nabumetone—Agitation—Topiramate—epilepsy syndrome	4.91e-05	0.000276	CcSEcCtD
Nabumetone—Fatigue—Pregabalin—epilepsy syndrome	4.87e-05	0.000274	CcSEcCtD
Nabumetone—Nausea—Carbamazepine—epilepsy syndrome	4.83e-05	0.000272	CcSEcCtD
Nabumetone—Constipation—Pregabalin—epilepsy syndrome	4.83e-05	0.000272	CcSEcCtD
Nabumetone—Malaise—Topiramate—epilepsy syndrome	4.82e-05	0.000271	CcSEcCtD
Nabumetone—Vertigo—Topiramate—epilepsy syndrome	4.8e-05	0.00027	CcSEcCtD
Nabumetone—Syncope—Topiramate—epilepsy syndrome	4.79e-05	0.00027	CcSEcCtD
Nabumetone—Leukopenia—Topiramate—epilepsy syndrome	4.78e-05	0.000269	CcSEcCtD
Nabumetone—Palpitations—Topiramate—epilepsy syndrome	4.72e-05	0.000266	CcSEcCtD
Nabumetone—Loss of consciousness—Topiramate—epilepsy syndrome	4.69e-05	0.000264	CcSEcCtD
Nabumetone—Insomnia—Gabapentin—epilepsy syndrome	4.68e-05	0.000264	CcSEcCtD
Nabumetone—Nausea—Lamotrigine—epilepsy syndrome	4.67e-05	0.000263	CcSEcCtD
Nabumetone—Cough—Topiramate—epilepsy syndrome	4.66e-05	0.000262	CcSEcCtD
Nabumetone—Feeling abnormal—Pregabalin—epilepsy syndrome	4.65e-05	0.000262	CcSEcCtD
Nabumetone—Paraesthesia—Gabapentin—epilepsy syndrome	4.65e-05	0.000262	CcSEcCtD
Nabumetone—Gastrointestinal pain—Pregabalin—epilepsy syndrome	4.62e-05	0.00026	CcSEcCtD
Nabumetone—Dyspnoea—Gabapentin—epilepsy syndrome	4.62e-05	0.00026	CcSEcCtD
Nabumetone—Hypertension—Topiramate—epilepsy syndrome	4.61e-05	0.00026	CcSEcCtD
Nabumetone—Somnolence—Gabapentin—epilepsy syndrome	4.6e-05	0.000259	CcSEcCtD
Nabumetone—Hypersensitivity—Valproic Acid—epilepsy syndrome	4.6e-05	0.000259	CcSEcCtD
Nabumetone—Dyspepsia—Gabapentin—epilepsy syndrome	4.56e-05	0.000257	CcSEcCtD
Nabumetone—Anxiety—Topiramate—epilepsy syndrome	4.53e-05	0.000255	CcSEcCtD
Nabumetone—Decreased appetite—Gabapentin—epilepsy syndrome	4.5e-05	0.000254	CcSEcCtD
Nabumetone—Discomfort—Topiramate—epilepsy syndrome	4.49e-05	0.000253	CcSEcCtD
Nabumetone—Urticaria—Pregabalin—epilepsy syndrome	4.49e-05	0.000253	CcSEcCtD
Nabumetone—Asthenia—Valproic Acid—epilepsy syndrome	4.48e-05	0.000252	CcSEcCtD
Nabumetone—Fatigue—Gabapentin—epilepsy syndrome	4.47e-05	0.000252	CcSEcCtD
Nabumetone—Abdominal pain—Pregabalin—epilepsy syndrome	4.47e-05	0.000252	CcSEcCtD
Nabumetone—Body temperature increased—Pregabalin—epilepsy syndrome	4.47e-05	0.000252	CcSEcCtD
Nabumetone—Dry mouth—Topiramate—epilepsy syndrome	4.45e-05	0.00025	CcSEcCtD
Nabumetone—Constipation—Gabapentin—epilepsy syndrome	4.43e-05	0.000249	CcSEcCtD
Nabumetone—Pruritus—Valproic Acid—epilepsy syndrome	4.42e-05	0.000249	CcSEcCtD
Nabumetone—Confusional state—Topiramate—epilepsy syndrome	4.39e-05	0.000247	CcSEcCtD
Nabumetone—Oedema—Topiramate—epilepsy syndrome	4.36e-05	0.000245	CcSEcCtD
Nabumetone—Shock—Topiramate—epilepsy syndrome	4.29e-05	0.000241	CcSEcCtD
Nabumetone—Diarrhoea—Valproic Acid—epilepsy syndrome	4.28e-05	0.000241	CcSEcCtD
Nabumetone—Feeling abnormal—Gabapentin—epilepsy syndrome	4.27e-05	0.00024	CcSEcCtD
Nabumetone—Thrombocytopenia—Topiramate—epilepsy syndrome	4.27e-05	0.00024	CcSEcCtD
Nabumetone—Gastrointestinal pain—Gabapentin—epilepsy syndrome	4.24e-05	0.000239	CcSEcCtD
Nabumetone—Hyperhidrosis—Topiramate—epilepsy syndrome	4.21e-05	0.000237	CcSEcCtD
Nabumetone—Hypersensitivity—Pregabalin—epilepsy syndrome	4.16e-05	0.000234	CcSEcCtD
Nabumetone—Anorexia—Topiramate—epilepsy syndrome	4.15e-05	0.000234	CcSEcCtD
Nabumetone—Dizziness—Valproic Acid—epilepsy syndrome	4.13e-05	0.000233	CcSEcCtD
Nabumetone—Urticaria—Gabapentin—epilepsy syndrome	4.11e-05	0.000232	CcSEcCtD
Nabumetone—Abdominal pain—Gabapentin—epilepsy syndrome	4.09e-05	0.000231	CcSEcCtD
Nabumetone—Body temperature increased—Gabapentin—epilepsy syndrome	4.09e-05	0.000231	CcSEcCtD
Nabumetone—Asthenia—Pregabalin—epilepsy syndrome	4.05e-05	0.000228	CcSEcCtD
Nabumetone—Pruritus—Pregabalin—epilepsy syndrome	4e-05	0.000225	CcSEcCtD
Nabumetone—Vomiting—Valproic Acid—epilepsy syndrome	3.97e-05	0.000224	CcSEcCtD
Nabumetone—Insomnia—Topiramate—epilepsy syndrome	3.94e-05	0.000222	CcSEcCtD
Nabumetone—Rash—Valproic Acid—epilepsy syndrome	3.94e-05	0.000222	CcSEcCtD
Nabumetone—Dermatitis—Valproic Acid—epilepsy syndrome	3.94e-05	0.000222	CcSEcCtD
Nabumetone—Headache—Valproic Acid—epilepsy syndrome	3.91e-05	0.00022	CcSEcCtD
Nabumetone—Paraesthesia—Topiramate—epilepsy syndrome	3.91e-05	0.00022	CcSEcCtD
Nabumetone—Dyspnoea—Topiramate—epilepsy syndrome	3.89e-05	0.000219	CcSEcCtD
Nabumetone—Somnolence—Topiramate—epilepsy syndrome	3.87e-05	0.000218	CcSEcCtD
Nabumetone—Diarrhoea—Pregabalin—epilepsy syndrome	3.86e-05	0.000218	CcSEcCtD
Nabumetone—Dyspepsia—Topiramate—epilepsy syndrome	3.84e-05	0.000216	CcSEcCtD
Nabumetone—Hypersensitivity—Gabapentin—epilepsy syndrome	3.82e-05	0.000215	CcSEcCtD
Nabumetone—Decreased appetite—Topiramate—epilepsy syndrome	3.79e-05	0.000213	CcSEcCtD
Nabumetone—Fatigue—Topiramate—epilepsy syndrome	3.76e-05	0.000212	CcSEcCtD
Nabumetone—Dizziness—Pregabalin—epilepsy syndrome	3.74e-05	0.00021	CcSEcCtD
Nabumetone—Constipation—Topiramate—epilepsy syndrome	3.73e-05	0.00021	CcSEcCtD
Nabumetone—Asthenia—Gabapentin—epilepsy syndrome	3.72e-05	0.000209	CcSEcCtD
Nabumetone—Nausea—Valproic Acid—epilepsy syndrome	3.71e-05	0.000209	CcSEcCtD
Nabumetone—Pruritus—Gabapentin—epilepsy syndrome	3.66e-05	0.000206	CcSEcCtD
Nabumetone—Vomiting—Pregabalin—epilepsy syndrome	3.59e-05	0.000202	CcSEcCtD
Nabumetone—Feeling abnormal—Topiramate—epilepsy syndrome	3.59e-05	0.000202	CcSEcCtD
Nabumetone—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.56e-05	0.000201	CcSEcCtD
Nabumetone—Rash—Pregabalin—epilepsy syndrome	3.56e-05	0.000201	CcSEcCtD
Nabumetone—Dermatitis—Pregabalin—epilepsy syndrome	3.56e-05	0.0002	CcSEcCtD
Nabumetone—Diarrhoea—Gabapentin—epilepsy syndrome	3.54e-05	0.0002	CcSEcCtD
Nabumetone—Headache—Pregabalin—epilepsy syndrome	3.54e-05	0.000199	CcSEcCtD
Nabumetone—Urticaria—Topiramate—epilepsy syndrome	3.46e-05	0.000195	CcSEcCtD
Nabumetone—Body temperature increased—Topiramate—epilepsy syndrome	3.44e-05	0.000194	CcSEcCtD
Nabumetone—Abdominal pain—Topiramate—epilepsy syndrome	3.44e-05	0.000194	CcSEcCtD
Nabumetone—Dizziness—Gabapentin—epilepsy syndrome	3.43e-05	0.000193	CcSEcCtD
Nabumetone—Nausea—Pregabalin—epilepsy syndrome	3.36e-05	0.000189	CcSEcCtD
Nabumetone—Vomiting—Gabapentin—epilepsy syndrome	3.29e-05	0.000185	CcSEcCtD
Nabumetone—Rash—Gabapentin—epilepsy syndrome	3.27e-05	0.000184	CcSEcCtD
Nabumetone—Dermatitis—Gabapentin—epilepsy syndrome	3.26e-05	0.000184	CcSEcCtD
Nabumetone—Headache—Gabapentin—epilepsy syndrome	3.24e-05	0.000183	CcSEcCtD
Nabumetone—Hypersensitivity—Topiramate—epilepsy syndrome	3.21e-05	0.000181	CcSEcCtD
Nabumetone—Asthenia—Topiramate—epilepsy syndrome	3.13e-05	0.000176	CcSEcCtD
Nabumetone—Pruritus—Topiramate—epilepsy syndrome	3.08e-05	0.000174	CcSEcCtD
Nabumetone—Nausea—Gabapentin—epilepsy syndrome	3.08e-05	0.000173	CcSEcCtD
Nabumetone—Diarrhoea—Topiramate—epilepsy syndrome	2.98e-05	0.000168	CcSEcCtD
Nabumetone—CYP1A2—Metapathway biotransformation—CYP11A1—epilepsy syndrome	2.98e-05	0.000904	CbGpPWpGaD
Nabumetone—PTGS1—Biological oxidations—POMC—epilepsy syndrome	2.97e-05	0.000902	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	2.96e-05	0.000897	CbGpPWpGaD
Nabumetone—Dizziness—Topiramate—epilepsy syndrome	2.88e-05	0.000162	CcSEcCtD
Nabumetone—CYP1A2—Arachidonic acid metabolism—PTGS2—epilepsy syndrome	2.86e-05	0.000869	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—epilepsy syndrome	2.85e-05	0.000864	CbGpPWpGaD
Nabumetone—PTGS2—Disease—SV2A—epilepsy syndrome	2.83e-05	0.000858	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—COX3—epilepsy syndrome	2.8e-05	0.000851	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PDXK—epilepsy syndrome	2.78e-05	0.000845	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CERS1—epilepsy syndrome	2.78e-05	0.000845	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—FAR1—epilepsy syndrome	2.78e-05	0.000845	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ADK—epilepsy syndrome	2.78e-05	0.000845	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GLUD1—epilepsy syndrome	2.78e-05	0.000845	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—L2HGDH—epilepsy syndrome	2.78e-05	0.000845	CbGpPWpGaD
Nabumetone—Vomiting—Topiramate—epilepsy syndrome	2.77e-05	0.000156	CcSEcCtD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—epilepsy syndrome	2.76e-05	0.000837	CbGpPWpGaD
Nabumetone—Rash—Topiramate—epilepsy syndrome	2.75e-05	0.000155	CcSEcCtD
Nabumetone—Dermatitis—Topiramate—epilepsy syndrome	2.75e-05	0.000155	CcSEcCtD
Nabumetone—PTGS1—Selenium Micronutrient Network—TNF—epilepsy syndrome	2.74e-05	0.00083	CbGpPWpGaD
Nabumetone—Headache—Topiramate—epilepsy syndrome	2.73e-05	0.000154	CcSEcCtD
Nabumetone—CYP1A2—Biological oxidations—CYP2D6—epilepsy syndrome	2.73e-05	0.000827	CbGpPWpGaD
Nabumetone—CYP1A2—Metapathway biotransformation—CYP2D6—epilepsy syndrome	2.69e-05	0.000816	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	2.68e-05	0.000814	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CACNA2D2—epilepsy syndrome	2.66e-05	0.000807	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PFKL—epilepsy syndrome	2.66e-05	0.000807	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—KCNB1—epilepsy syndrome	2.66e-05	0.000807	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—SLCO1A2—epilepsy syndrome	2.66e-05	0.000807	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—SLC6A8—epilepsy syndrome	2.66e-05	0.000807	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	2.6e-05	0.000788	CbGpPWpGaD
Nabumetone—Nausea—Topiramate—epilepsy syndrome	2.59e-05	0.000146	CcSEcCtD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	2.58e-05	0.000784	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NHLRC1—epilepsy syndrome	2.55e-05	0.000773	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—EPM2A—epilepsy syndrome	2.55e-05	0.000773	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PNPO—epilepsy syndrome	2.55e-05	0.000773	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GAMT—epilepsy syndrome	2.55e-05	0.000773	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PFKL—epilepsy syndrome	2.52e-05	0.000765	CbGpPWpGaD
Nabumetone—CYP1A2—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	2.51e-05	0.000763	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—SRC—epilepsy syndrome	2.47e-05	0.000751	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—epilepsy syndrome	2.47e-05	0.000751	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	2.45e-05	0.000744	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	2.43e-05	0.000738	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—UPB1—epilepsy syndrome	2.43e-05	0.000738	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ATIC—epilepsy syndrome	2.43e-05	0.000738	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—NEU1—epilepsy syndrome	2.43e-05	0.000738	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—epilepsy syndrome	2.41e-05	0.000731	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IL1B—epilepsy syndrome	2.37e-05	0.000718	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—QDPR—epilepsy syndrome	2.37e-05	0.000718	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CA4—epilepsy syndrome	2.37e-05	0.000718	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—CASP3—epilepsy syndrome	2.36e-05	0.000717	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	2.36e-05	0.000716	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—HSD17B4—epilepsy syndrome	2.34e-05	0.00071	CbGpPWpGaD
Nabumetone—PTGS2—Disease—STX1B—epilepsy syndrome	2.3e-05	0.000699	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GBE1—epilepsy syndrome	2.26e-05	0.000686	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PPP1R3C—epilepsy syndrome	2.26e-05	0.000686	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—MMP9—epilepsy syndrome	2.23e-05	0.000677	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—COX3—epilepsy syndrome	2.23e-05	0.000676	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	2.21e-05	0.00067	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—TNF—epilepsy syndrome	2.17e-05	0.000659	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	2.14e-05	0.000651	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PPP1R3C—epilepsy syndrome	2.14e-05	0.00065	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CPSF4—epilepsy syndrome	2.14e-05	0.00065	CbGpPWpGaD
Nabumetone—PTGS2—Disease—GBE1—epilepsy syndrome	2.14e-05	0.00065	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ASAH1—epilepsy syndrome	2.12e-05	0.000645	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	2.12e-05	0.000644	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—KCNB1—epilepsy syndrome	2.11e-05	0.00064	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PFKL—epilepsy syndrome	2.11e-05	0.00064	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—SLCO1A2—epilepsy syndrome	2.11e-05	0.00064	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CACNA2D2—epilepsy syndrome	2.11e-05	0.00064	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—SLC6A8—epilepsy syndrome	2.11e-05	0.00064	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CA13—epilepsy syndrome	2.08e-05	0.000631	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—STXBP1—epilepsy syndrome	2.07e-05	0.000627	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—epilepsy syndrome	2.07e-05	0.000627	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—epilepsy syndrome	2.07e-05	0.000627	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	2.06e-05	0.000626	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	2.05e-05	0.000622	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—NT5E—epilepsy syndrome	2.01e-05	0.000611	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ALAD—epilepsy syndrome	2.01e-05	0.000611	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ATIC—epilepsy syndrome	1.93e-05	0.000586	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NEU1—epilepsy syndrome	1.93e-05	0.000586	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—UPB1—epilepsy syndrome	1.93e-05	0.000586	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ALDH7A1—epilepsy syndrome	1.92e-05	0.000583	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CACNA1A—epilepsy syndrome	1.92e-05	0.000583	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	1.92e-05	0.000582	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ST3GAL3—epilepsy syndrome	1.88e-05	0.000571	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—HSD17B4—epilepsy syndrome	1.86e-05	0.000564	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ADSL—epilepsy syndrome	1.84e-05	0.000559	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	1.82e-05	0.000553	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GLUL—epilepsy syndrome	1.81e-05	0.000548	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PPP1R3C—epilepsy syndrome	1.79e-05	0.000545	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GBE1—epilepsy syndrome	1.79e-05	0.000545	CbGpPWpGaD
Nabumetone—PTGS2—Disease—ST3GAL3—epilepsy syndrome	1.78e-05	0.000541	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CACNA1D—epilepsy syndrome	1.77e-05	0.000538	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.75e-05	0.000532	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—TNF—epilepsy syndrome	1.72e-05	0.000521	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ASAH1—epilepsy syndrome	1.69e-05	0.000512	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	1.67e-05	0.000508	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—TXNRD1—epilepsy syndrome	1.66e-05	0.000503	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—STXBP1—epilepsy syndrome	1.64e-05	0.000498	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—AQP1—epilepsy syndrome	1.61e-05	0.000489	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	1.61e-05	0.000488	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NT5E—epilepsy syndrome	1.6e-05	0.000485	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ALAD—epilepsy syndrome	1.6e-05	0.000485	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PDXK—epilepsy syndrome	1.58e-05	0.000478	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ADK—epilepsy syndrome	1.58e-05	0.000478	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CERS1—epilepsy syndrome	1.58e-05	0.000478	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GLUD1—epilepsy syndrome	1.58e-05	0.000478	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—L2HGDH—epilepsy syndrome	1.58e-05	0.000478	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—FAR1—epilepsy syndrome	1.58e-05	0.000478	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	1.56e-05	0.000474	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.55e-05	0.000469	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ALDH7A1—epilepsy syndrome	1.53e-05	0.000463	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CACNA1A—epilepsy syndrome	1.53e-05	0.000463	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ST3GAL3—epilepsy syndrome	1.49e-05	0.000453	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ADSL—epilepsy syndrome	1.46e-05	0.000444	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CHRM3—epilepsy syndrome	1.46e-05	0.000442	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—KCNJ11—epilepsy syndrome	1.46e-05	0.000442	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PNPO—epilepsy syndrome	1.44e-05	0.000437	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GAMT—epilepsy syndrome	1.44e-05	0.000437	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—EPM2A—epilepsy syndrome	1.44e-05	0.000437	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NHLRC1—epilepsy syndrome	1.44e-05	0.000437	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GLUL—epilepsy syndrome	1.43e-05	0.000435	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CACNA1D—epilepsy syndrome	1.41e-05	0.000427	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	1.4e-05	0.000425	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	1.36e-05	0.000414	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.36e-05	0.000412	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CA4—epilepsy syndrome	1.34e-05	0.000407	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—QDPR—epilepsy syndrome	1.34e-05	0.000407	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—POMC—epilepsy syndrome	1.34e-05	0.000405	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.33e-05	0.000403	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—TXNRD1—epilepsy syndrome	1.32e-05	0.0004	CbGpPWpGaD
Nabumetone—PTGS2—Disease—EIF2AK2—epilepsy syndrome	1.3e-05	0.000394	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—AQP1—epilepsy syndrome	1.28e-05	0.000388	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—COX3—epilepsy syndrome	1.26e-05	0.000382	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.23e-05	0.000373	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PPIA—epilepsy syndrome	1.2e-05	0.000364	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SLCO1A2—epilepsy syndrome	1.19e-05	0.000362	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CACNA2D2—epilepsy syndrome	1.19e-05	0.000362	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—KCNB1—epilepsy syndrome	1.19e-05	0.000362	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PFKL—epilepsy syndrome	1.19e-05	0.000362	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SLC6A8—epilepsy syndrome	1.19e-05	0.000362	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ABCG2—epilepsy syndrome	1.19e-05	0.00036	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	1.17e-05	0.000355	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.17e-05	0.000354	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.16e-05	0.000352	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CYP2C19—epilepsy syndrome	1.16e-05	0.000351	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—KCNJ11—epilepsy syndrome	1.16e-05	0.000351	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CHRM3—epilepsy syndrome	1.16e-05	0.000351	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CYP11A1—epilepsy syndrome	1.15e-05	0.000349	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.14e-05	0.000346	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—UPB1—epilepsy syndrome	1.09e-05	0.000331	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NEU1—epilepsy syndrome	1.09e-05	0.000331	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ATIC—epilepsy syndrome	1.09e-05	0.000331	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.08e-05	0.000327	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.05e-05	0.00032	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	1.05e-05	0.000319	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.04e-05	0.000316	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CYP2D6—epilepsy syndrome	1.04e-05	0.000315	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	1.02e-05	0.000308	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GBE1—epilepsy syndrome	1.02e-05	0.000308	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	9.92e-06	0.000301	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ADRA2A—epilepsy syndrome	9.88e-06	0.0003	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—BCHE—epilepsy syndrome	9.84e-06	0.000299	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	9.54e-06	0.00029	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ABCG2—epilepsy syndrome	9.42e-06	0.000286	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—SLC2A1—epilepsy syndrome	9.38e-06	0.000285	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	9.29e-06	0.000282	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PLCB1—epilepsy syndrome	9.28e-06	0.000282	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—TH—epilepsy syndrome	9.25e-06	0.000281	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYP2C19—epilepsy syndrome	9.18e-06	0.000279	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYP11A1—epilepsy syndrome	9.13e-06	0.000277	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	9.1e-06	0.000276	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	9.06e-06	0.000275	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NT5E—epilepsy syndrome	9.05e-06	0.000275	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ALAD—epilepsy syndrome	9.05e-06	0.000275	CbGpPWpGaD
Nabumetone—PTGS2—Disease—SLC2A1—epilepsy syndrome	8.9e-06	0.00027	CbGpPWpGaD
Nabumetone—PTGS2—Disease—JUNB—epilepsy syndrome	8.83e-06	0.000268	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NOS1—epilepsy syndrome	8.77e-06	0.000266	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	8.7e-06	0.000264	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	8.63e-06	0.000262	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	8.63e-06	0.000262	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	8.45e-06	0.000256	CbGpPWpGaD
Nabumetone—PTGS2—Disease—HBEGF—epilepsy syndrome	8.36e-06	0.000254	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ADSL—epilepsy syndrome	8.28e-06	0.000251	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	8.26e-06	0.000251	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYP2D6—epilepsy syndrome	8.24e-06	0.00025	CbGpPWpGaD
Nabumetone—PTGS2—Disease—AKT3—epilepsy syndrome	8.21e-06	0.000249	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GLUL—epilepsy syndrome	8.12e-06	0.000246	CbGpPWpGaD
Nabumetone—PTGS2—Disease—ADAM10—epilepsy syndrome	8.02e-06	0.000243	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	7.97e-06	0.000242	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ADRA2A—epilepsy syndrome	7.84e-06	0.000238	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—BCHE—epilepsy syndrome	7.81e-06	0.000237	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—HMOX1—epilepsy syndrome	7.72e-06	0.000234	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CAT—epilepsy syndrome	7.62e-06	0.000231	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CDC42—epilepsy syndrome	7.49e-06	0.000227	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	7.45e-06	0.000226	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—SLC2A1—epilepsy syndrome	7.45e-06	0.000226	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ABCB1—epilepsy syndrome	7.41e-06	0.000225	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PLCB1—epilepsy syndrome	7.37e-06	0.000224	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—TH—epilepsy syndrome	7.34e-06	0.000223	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—AQP1—epilepsy syndrome	7.23e-06	0.00022	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	6.95e-06	0.000211	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GPX1—epilepsy syndrome	6.89e-06	0.000209	CbGpPWpGaD
Nabumetone—PTGS2—Disease—HES1—epilepsy syndrome	6.86e-06	0.000208	CbGpPWpGaD
Nabumetone—PTGS2—Disease—FYN—epilepsy syndrome	6.67e-06	0.000202	CbGpPWpGaD
Nabumetone—PTGS2—Disease—H2AFX—epilepsy syndrome	6.64e-06	0.000202	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	6.54e-06	0.000199	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	6.54e-06	0.000199	CbGpPWpGaD
Nabumetone—PTGS2—Disease—YWHAZ—epilepsy syndrome	6.41e-06	0.000195	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CCR5—epilepsy syndrome	6.17e-06	0.000187	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—HMOX1—epilepsy syndrome	6.13e-06	0.000186	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	6.09e-06	0.000185	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CAT—epilepsy syndrome	6.05e-06	0.000184	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—AGT—epilepsy syndrome	6.04e-06	0.000183	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.97e-06	0.000181	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—APOE—epilepsy syndrome	5.92e-06	0.00018	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ABCB1—epilepsy syndrome	5.88e-06	0.000179	CbGpPWpGaD
Nabumetone—PTGS2—Disease—TSC2—epilepsy syndrome	5.73e-06	0.000174	CbGpPWpGaD
Nabumetone—PTGS2—Disease—APOE—epilepsy syndrome	5.61e-06	0.00017	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GPX1—epilepsy syndrome	5.47e-06	0.000166	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	5.33e-06	0.000162	CbGpPWpGaD
Nabumetone—PTGS2—Disease—IL6ST—epilepsy syndrome	5.27e-06	0.00016	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NOS2—epilepsy syndrome	5.23e-06	0.000159	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	5.2e-06	0.000158	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	5.16e-06	0.000157	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	5.13e-06	0.000156	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—POMC—epilepsy syndrome	5.08e-06	0.000154	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—AGT—epilepsy syndrome	4.79e-06	0.000146	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—APOE—epilepsy syndrome	4.7e-06	0.000143	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.68e-06	0.000142	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	4.66e-06	0.000141	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ALB—epilepsy syndrome	4.63e-06	0.000141	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	4.44e-06	0.000135	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—BCHE—epilepsy syndrome	4.42e-06	0.000134	CbGpPWpGaD
Nabumetone—PTGS2—Disease—FGF2—epilepsy syndrome	4.26e-06	0.000129	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	4.22e-06	0.000128	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	4.17e-06	0.000127	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—TH—epilepsy syndrome	4.15e-06	0.000126	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.09e-06	0.000124	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PTGS2—epilepsy syndrome	4.05e-06	0.000123	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—POMC—epilepsy syndrome	4.04e-06	0.000122	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MTOR—epilepsy syndrome	3.88e-06	0.000118	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ALB—epilepsy syndrome	3.68e-06	0.000112	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	3.47e-06	0.000105	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CAT—epilepsy syndrome	3.42e-06	0.000104	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	3.33e-06	0.000101	CbGpPWpGaD
Nabumetone—PTGS2—Disease—SRC—epilepsy syndrome	3.11e-06	9.43e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GPX1—epilepsy syndrome	3.09e-06	9.39e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—AGT—epilepsy syndrome	2.71e-06	8.23e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—APOE—epilepsy syndrome	2.66e-06	8.07e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—POMC—epilepsy syndrome	2.28e-06	6.93e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ALB—epilepsy syndrome	2.08e-06	6.32e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—AKT1—epilepsy syndrome	2.04e-06	6.19e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—AKT1—epilepsy syndrome	1.93e-06	5.86e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	1.82e-06	5.53e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—AKT1—epilepsy syndrome	1.62e-06	4.91e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—AKT1—epilepsy syndrome	9.15e-07	2.78e-05	CbGpPWpGaD
